EUVIMEDEUVIMED entdecken
Open Access · CC0

Identification of immune pathways regulating the cell mediated immunity in leishmaniasis in humans

Saeed Mohammed Abdelrahim, Khalil Eltahir Awad Gasim, Younis Brima Musa, Spyros Karaiskos, Luis Santana-Quintero, Hira L. Nakhasi, Musa Ahmed Mudawi, Sreenivas Gannavaram, Abhay R. Satoskar

PLOS Neglected Tropical Diseases · 20.11.2026 · 20 (11) · e0014743

DOI: 10.1371/journal.pntd.0014743 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 20.11.2026. Verfasst von Saeed Mohammed Abdelrahim und 8 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Global Innovation Technology Fund, U.S. Food and Drug Administration (FDA) – Intramural Funds.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A delayed-type hypersensitivity (DTH) response induced by the intradermal inoculation of leishmanin antigen induced in individuals exposed to parasite Leishmania is a reliable indicator of cell mediated immunity (CMI). Leishmanin antigen skin test (LST) is also an important tool in disease surveillance studies in endemic area and can be used to assess vaccine efficacy. Previous studies assessing CMI in Leishmania exposed individuals were limited to analysis of PBMCs. To investigate the mediators of CMI, we performed spatial transcriptomic analysis of the DTH skin biopsies after leishmanin antigen inoculation from individuals living in Leishmania endemic foci. Compared to healthy skin biopsy, macrophages and T cells, associated with a positive DTH response and the cytokines IL-16 and TNF that attract CD4 + T cells, were elevated in Langerhans cells in the DTH biopsies. Both IFN-γ receptors were similarly elevated in the DTH biopsies. Chemokines CCL2, CCL5, CCL8 and CCL19, and the corresponding receptors were elevated in DTH biopsies, with CCL19-CCR7 as the most salient interaction in our CellChat analysis. These data reveal biomarkers of DTH response following leishmanin inoculation and enable appropriate formulation and reintroduction of leishmanin skin test antigens for disease surveillance.

Förderung

  • Global Innovation Technology Fund
  • U.S. Food and Drug Administration (FDA) – Intramural Funds

Zitieren

APA

Abdelrahim, S. M., Gasim, K. E. A., Musa, Y. B., Karaiskos, S., Santana-Quintero, L., Nakhasi, H. L., Mudawi, M. A., Gannavaram, S., & Satoskar, A. R. (2026). Identification of immune pathways regulating the cell mediated immunity in leishmaniasis in humans. PLOS Neglected Tropical Diseases, 20(11), e0014743. https://doi.org/10.1371/journal.pntd.0014743

Vancouver

Abdelrahim SM, Gasim KEA, Musa YB, Karaiskos S, Santana-Quintero L, Nakhasi HL, et al. Identification of immune pathways regulating the cell mediated immunity in leishmaniasis in humans. PLOS Neglected Tropical Diseases. 2026;20(11):e0014743. doi:10.1371/journal.pntd.0014743

BibTeX
@article{Abdelrahim2026,
  author = {Abdelrahim, Saeed Mohammed and Gasim, Khalil Eltahir Awad and Musa, Younis Brima and Karaiskos, Spyros and Santana-Quintero, Luis and Nakhasi, Hira L. and Mudawi, Musa Ahmed and Gannavaram, Sreenivas and Satoskar, Abhay R.},
  title = {Identification of immune pathways regulating the cell mediated immunity in leishmaniasis in humans},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2026},
  volume = {20},
  number = {11},
  pages = {e0014743},
  doi = {10.1371/journal.pntd.0014743}
}
Kostenlos starten →